中国肺癌杂志
中國肺癌雜誌
중국폐암잡지
CHINESE JOURNAL OF LUNG CANCER
2015年
8期
512-517
,共6页
杨梅%樊骏%周红霞%杜恒%邱舫%林琳%刘伦旭%李为民%车国卫
楊梅%樊駿%週紅霞%杜恆%邱舫%林琳%劉倫旭%李為民%車國衛
양매%번준%주홍하%두항%구방%림림%류륜욱%리위민%차국위
胸腔引流管大小%胸腔镜肺叶切除术%肺肿瘤
胸腔引流管大小%胸腔鏡肺葉切除術%肺腫瘤
흉강인류관대소%흉강경폐협절제술%폐종류
Chest tube size%VATS lobectomy%Lung neoplasms
背景与目的微创胸外科术后管理仍延用开放术后的方式,尤其是胸腔引流管的术后管理,本研究探讨胸腔镜(video-assisted thoracic surgery, VATS)肺叶切除术后应用胸腔引流管(16 F)对切口愈合延迟的影响,是否因引流管管径小而导致相关并发症的增多。方法选取2014年2月-2014年5月四川大学华西医院连续收治的163例肺癌行VATS肺叶切除术,分别应用引流管28 F(75例)和16 F(88例),分析术后胸腔积气、积液、皮下气肿、引流管持续时间、术后住院日、术后引流管拆线时间和切口愈合率。结果平均引流量和心律失常发生率在16 F组[(365±106) mL,14.67%]明显低于28 F组[(665±217) mL,4.5%](P=0.030,1,P=0.047);术后胸腔积气、积液和皮下气肿在28 F组发生率(4.00%,0.0%,7.50%)与16 F组(4.50%,3.41%,6.82%)均无统计学差异(P<0.999,P=0.253,P=0.789);引流管持续时间及术后平均住院日在16F组[(22.1±11.8) h,(4.23±0.05) d]与28 F组[(28.4±16.12) h,(4.57±0.16) d]均无统计学差异(P=0.12,P=0.078);引流管拆线时间在16 F组(7.05±2.11)d明显短于28 F组(14.33±3.87)d(P=0.034);切口一级愈合率在16 F组(95.45%)明显高于28 F组(77.73%)(P=0.039)。结论胸腔镜肺叶切除术后16 F和28 F引流临床效果相当,而16 F有助于引流管口快速愈合。
揹景與目的微創胸外科術後管理仍延用開放術後的方式,尤其是胸腔引流管的術後管理,本研究探討胸腔鏡(video-assisted thoracic surgery, VATS)肺葉切除術後應用胸腔引流管(16 F)對切口愈閤延遲的影響,是否因引流管管徑小而導緻相關併髮癥的增多。方法選取2014年2月-2014年5月四川大學華西醫院連續收治的163例肺癌行VATS肺葉切除術,分彆應用引流管28 F(75例)和16 F(88例),分析術後胸腔積氣、積液、皮下氣腫、引流管持續時間、術後住院日、術後引流管拆線時間和切口愈閤率。結果平均引流量和心律失常髮生率在16 F組[(365±106) mL,14.67%]明顯低于28 F組[(665±217) mL,4.5%](P=0.030,1,P=0.047);術後胸腔積氣、積液和皮下氣腫在28 F組髮生率(4.00%,0.0%,7.50%)與16 F組(4.50%,3.41%,6.82%)均無統計學差異(P<0.999,P=0.253,P=0.789);引流管持續時間及術後平均住院日在16F組[(22.1±11.8) h,(4.23±0.05) d]與28 F組[(28.4±16.12) h,(4.57±0.16) d]均無統計學差異(P=0.12,P=0.078);引流管拆線時間在16 F組(7.05±2.11)d明顯短于28 F組(14.33±3.87)d(P=0.034);切口一級愈閤率在16 F組(95.45%)明顯高于28 F組(77.73%)(P=0.039)。結論胸腔鏡肺葉切除術後16 F和28 F引流臨床效果相噹,而16 F有助于引流管口快速愈閤。
배경여목적미창흉외과술후관리잉연용개방술후적방식,우기시흉강인류관적술후관리,본연구탐토흉강경(video-assisted thoracic surgery, VATS)폐협절제술후응용흉강인류관(16 F)대절구유합연지적영향,시부인인류관관경소이도치상관병발증적증다。방법선취2014년2월-2014년5월사천대학화서의원련속수치적163례폐암행VATS폐협절제술,분별응용인류관28 F(75례)화16 F(88례),분석술후흉강적기、적액、피하기종、인류관지속시간、술후주원일、술후인류관탁선시간화절구유합솔。결과평균인류량화심률실상발생솔재16 F조[(365±106) mL,14.67%]명현저우28 F조[(665±217) mL,4.5%](P=0.030,1,P=0.047);술후흉강적기、적액화피하기종재28 F조발생솔(4.00%,0.0%,7.50%)여16 F조(4.50%,3.41%,6.82%)균무통계학차이(P<0.999,P=0.253,P=0.789);인류관지속시간급술후평균주원일재16F조[(22.1±11.8) h,(4.23±0.05) d]여28 F조[(28.4±16.12) h,(4.57±0.16) d]균무통계학차이(P=0.12,P=0.078);인류관탁선시간재16 F조(7.05±2.11)d명현단우28 F조(14.33±3.87)d(P=0.034);절구일급유합솔재16 F조(95.45%)명현고우28 F조(77.73%)(P=0.039)。결론흉강경폐협절제술후16 F화28 F인류림상효과상당,이16 F유조우인류관구쾌속유합。
Background and objective Post-operation management of minimally invasive thoracic surgery is simi-lar to that of open surgery, especially on the drainage tube of the chest. hTe aim of this study is to compare the advantages of us-ing 16 F versus 28 F chest tubes in video-assisted thoracoscopic surgery (VATS) lobectomy of lung cancer.Methods Data from 163 patients (February-May 2014) who underwent VATS lobectomy of lung cancer with insertion of one chest drain (16 F or 28 F) were analyzed. hTe following post-operative data were evaluated: primary healing of tube incision, CXR abnormalities (pneumothorax, lfuid, atelectasis, subcutaneous emphysema, and hematoma), drainage time, new drain insertion, and wound healing at the site of insertion.Results A total of 75 patients received 28 F chest tubes, and 88 patients received 16 F chest tubes. Both groups were similar in age, gender, comorbidities, and pathological evaluation of resection specimens. Atfer adjust-ment, no statistically signiifcant difference was found between the two groups in relation to tube-related complications includ-ing residual pneumothoraces (4.00%vs 4.44%;P=0.999), subcutaneous emphysema (8.00%vs 6.67%;P=0.789), retained hemothorax (0vs41%,P=0.253), and drainage time [(28.4±16.12) hvs(22.1±11.8) h;P=0.120)] hTe average total drainage volume and rrhythmia rates of the 16 F group [(365±106) mL, 14.67%)] was less than that of the 28 F group [(665±217) mL, 4.5%;P=0.030,P=0.047]. hTe rates of primary healing at the site of insertion in the 16 F group (95.45%) was higher than that in the 28 F group (77.73%,P=0.039). A signiifcant difference was found on the post-operative length of stay of the two groups [(4.23±0.05) dvs(4.57±0.16) d,P=0.078].Conclusion hTe use of 16 F chest tube for VATS lobectomy of patients with lung cancer did not affect the clinically relevant outcomes tested. However, 16 F chest tube facilitated faster wound healing at the site of insertion.